Learn More
Medchemexpress LLC N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)propanamide | 1005342-46-0 | MFCD23160049 | >99.0% | 500.6 g/mol | C26H33FN4O3S | 10 MG

Supplier: Medchemexpress LLC HY1551810MG
LCL161 is a small-molecule SMAC mimetic that antagonizes inhibitor-of-apoptosis proteins (IAPs). It is used in preclinical research to promote apoptosis and to sensitize cancer cells to cytotoxic therapies, showing potent activity at nanomolar concentrations.
- Potent IAP antagonist with nanomolar activity
- Inhibits XIAP in HEK293 cells (IC50 35 nM)
- Inhibits cIAP1 in MDA-MB-231 cells (IC50 0.4 nM)
- Acts as a SMAC mimetic to promote caspase activation
- Used to study apoptosis, cell death pathways, and combination therapy effects
- Molecular formula C26H33FN4O3S
- Molecular weight 500.6 g/mol
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.